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ABSTRACT
Introduction: Cervical cancer is the third most common
cancer among Malaysian women. Sarawak, the largest state
in Malaysia has consistently recorded the highest cervical
cancer rate in the country where nearly half of its population
still live in the rural areas and is at increased risk of the
disease due to inequitable access to healthcare. The
countrywide lockdown due to the COVID-19 pandemic had
halted the accessibility to cervical cancer screening
programme. The aim of the study is to determine the
feasibility of providing primary HPV DNA test using the self-
sampling method to the hard-to-reach population in the
interior of Sarawak during the COVID-19 pandemic.
Materials and Methods: This is a cross-sectional study
where women aged between 20-80 years were recruited via
convenient sampling from villages in Long Banga, Sarawak
over a five-day outreach programme. Cervicovaginal self-
samples were obtained and screened for the presence of
high-risk human papillomavirus DNA (HR-HPV) using the
careHPVTM Test. A self-administered questionnaire was also
administered to determine the sociodemographic and
perception towards the self-sampling method. 
Results: The 55 women recruited consist of ethnic
backgrounds of Penan (58.18%), Kenyah (25.45%), Iban
(5.45%), Saban (3.64%), Kelabit (3.64%), Malay (1.82%) and
Chinese (1.82%). The prevalence of HR-HPV was 1.85%
(n=1/55). Nearly 80% of the women were unemployed, and
more than half have had attended primary education. Nine
(16.4%) have heard about HPV, and seven (13%) knew HPV
infection could cause cervical cancer. Three of them had
HPV vaccination, and only one (1.85%) knew the brand of the
HPV vaccine. Although 40% preferred self-sampling over
clinician-collection, only ten (18.2%) women have completed
the self-collection perception questionnaire.
Conclusion: Primary HPV DNA screening using the self-
sampling method can be carried out in the remote areas
during the COVID-19 pandemic without compromising
mobility restriction. 
KEYWORDS: 
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INTRODUCTION
Cervical cancer (CC) is the second cause of death among
Malaysian women after breast cancer. It is ranked as the
third most common female cancer in Malaysia. CC is linked
to the persistent infection by one or more of the high-risk
human papillomavirus (HR-HPV), although other cofactors
such as multiple sex partners, early sexual debut, smoking,
and co-infection with Chlamydia trachomatis, have catalytic
effects on the oncogenic progression of HRHPV infection to
precancer and cancer.1,2 Currently, more than 200 human
papillomaviruses have been identified, with approximately
40 of them are sexually transmitted and 14 of them (HPV16,
18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) are
oncogenic and known as the HR-HPV.3 
Cervical cancer is one of a few preventable cancers by early
cervical cancer screening and effective vaccination. Cervical
cancer screening through Pap smear was begun in Malaysia
since 1969, and was gradually incorporated into the
postnatal care programme. Three decades later, the national
coverage is stagnant at around 22%, far below the
recommended coverage of 80% by the World Health
Organization (WHO).4,5
The strong association of HR-HPV infection with cervical
cancer has triggered the paradigm shift in CC prevention
strategies worldwide. For example, population-based HPV
vaccination using the bivalent HPV vaccine in many
countries has shown significant success in reducing  the rate
of CC.6 In addition to this, the more sensitive molecular
assays detecting the HRHPV genomic DNA are gaining
market share and is actively replacing Pap smear as the
primary cervical cancer screening tool in many countries
such as the Netherlands, Turkey, United Kingdom, Norway,
Italy, Sweden, Germany, and Finland, while many more are
in the transition state.7-9
Sarawak is the largest state in Malaysia with approximately
2.4 million people living on a 124,450 km2 land, making it
the least densely populated state. Nearly half the population
still lives in the rural areas and some in the remote villages10
with inequitable access to healthcare. It is not surprising that
Sarawak has consistently recorded the highest rate of CC in
the country, with the Age-Standardised Rate (ASR) of
12.1/100,000 compared to the national ASR of 6.2/100,000.11
Our study site was Long Banga (3.2015N, 115.4018E), a town
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within the district of Bario that lies in the deep interior of
Sarawak. Long Banga is located south of Bario and consists
of villages such as Long Lamei, Lio Mato, Long Spigen, Long
Kerong, and Long Sait. All these villages will be referred to as
Long Banga here. Due to its geographical location and
economic development, Long Banga is still devoid of road
access but is linked to Miri city via a 16-seat Twin Otter plane.
Its surrounding villages are connected to the main towns
(including Bario town) via logging trails and/or a network of
rivers. 
During the current COVID-19 pandemic, China has taken a
controversial measure to contain the spread of SARS-CoV-2
by locking down the entire 19 million population in Wuhan
city at the end of January 2020. Malaysia followed suit and
enforced a nationwide lockdown termed the Movement
Control Order (MCO) on the 18th March, 2020. The National
Cervical Cancer Screening Programme came to a halt. If this
situation remains, the delay in accessing essential healthcare
will likely see an increase in women presenting with late-
stage cervical cancer, a situation which will contribute to
both direct and indirect mortality from this preventable and
treatable disease.17-19 Even before the pandemic, as high as
76% of cervical cancer patients were only diagnosed at Stage
2 or worse.20
During the current MCO due to the COVID-19 pandemic, the
whole small district of Bario, including its surrounding
villages were cut off. Malaysia had eased the lockdown
restriction on the 4th May, 2020 under the Conditional
Movement Control Order (CMCO), restoring the courier
service to Bario. With this, we took the opportunity to study
the feasibility of providing primary HPV screening using the
self-sampling method to the hard-to-reach population in the
interior of Sarawak during the COVID-19 pandemic.
The HPV genotyping, follow-up testing, and the cytological
screening results are beyond the scope of this manuscript.
MATERIALS AND METHODS
Reaching the hard-to-reach communities
A convenient sampling method was employed in this
population-based HRHPV prevalence study, and we
envisaged to recruit as many participants as possible over the
5-day outreach programme during the CMCO period in May
2020. Recruitment in Long Banga includes non-virgin
females living in villages such as Long Banga itself, Long
Lamei, Lio Mato, Long Spigen, Long Kerong, and ends at
Long Sait (see Figure 1). 
Self-sampling kit
The self-collection kits were sent from Kota Samarahan to
Bario town using the national courier service. Every self-
collection kit consisted of a reusable ziplock bag containing a
careBrush (Qiagen, Shenzhen, China), one vial of
careMedium (Qiagen, Shenzhen, China), self-sampling
instruction, a patient information sheet with a questionnaire
and consent form.
The pictorial self-sampling instruction was adapted from the
Guidelines for Primary HPV Testing in Cervical Cancer
Screening in Malaysia 2019 (http://ogsm.org.my).
A questionnaire was included that consisted of questions
grouped in three parts: (1) sociodemographic and
socioeconomic factors like name, age, race, the highest level
of education, employment status - 5 questions; (2) awareness
and knowledge of about HPV infection - 4 questions; and
post-sampling - 4 questions. The questionnaire was pretested
on 90 women before being used.
Self-sampling
Participants were given time to go through the patient
information sheet, self-collection instruction, and complete
the questionnaire. Verbal instruction was given whenever
necessary. Women were allowed to perform self-collection in
their privacy. The instructions were the person was to take off
her undergarments and place one leg on a support such as a
chair or a toilet bowl. She then was to hold the free end of the
careBrush’s handle and gently push the other end with the
brush to the top of the vagina. When the careBrush was
inserted in her vagina, the woman was to turn the handle
two or three turns, remove the careBrush completely from her
vagina, and put it back into the careHPV™ Collection
Medium, snap the careBrush handle to break it, cap the tube,
and seal it with parafilm. Finally, she was to put the
specimen and other documents into the ziplock bag and
return it to the health volunteers. The specimens were then
consolidated and brought back to Bario town, air-flown to
Miri and couriered back to the Faculty of Medicine and
Health Sciences, Universiti Malaysia Sarawak at room
temperature.
HPV DNA Test and reporting
Samples were screened for HR-HPV DNA using the careHPV™
Test (Qiagen, Shenzhen, China) on 20th May, 2020. Results
were reported back to the health volunteers in Bario via
email, and the results are communicated to the participants
in-person. The HRHPV positive woman was triaged for further
screening according to the National Cervical Cancer
Screening Guideline, and those negative for HRHPV infection
were advised rescreening in 3-5 years later. 
This study was approved by the Universiti Malaysia Sarawak
Medical Ethics Committee (UNIMAS/NC-21.02/03-02
Jld.3(17). All participation was voluntary, and the
participants were briefed about the study, and they all
provided written informed consent before their participation.
RESULTS
The mean and median age of the participants was 40.5 and
39.5 years, respectively. The cohorts from 20-29, 30-39, and
40-49 years old represented 83.6% (n=46/55) of the sample
size. There was only one HRHPV positive woman detected,
which gives the prevalence of 1.85% in the population. The
sole HRHPV positive case was an unemployed Penan woman
in the 30-39 age cohort and had only attended primary
education (Table I). Only 5.5% (n=3/55) had attained tertiary
education; while 40% (n=22/55) and 54.5% (n=30/55) had
attended secondary and primary education (Table I).
Unemployment was high at 76.4% (n=42/55) as most of them
are housewives. Some 16.4% (n=9/55) are self-employed or
engaged in agricultural activities, and only 7.3% (n=4/55)
were employed and having a stable payroll (Table I).
4-Self-Sampling00184_3-PRIMARY.qxd  5/13/21  10:27 PM  Page 299
Original Article 
300 Med J Malaysia Vol 76 No 3 May 2021
All participants had completed the HPV literacy survey, with
most of them (83.6%; n=46/55) stated that they had never
heard about HPV. Only 16.4% (n=9/55) had heard about
HPV, with seven of them knew that HPV infection could lead
to cervical cancer. Of the 7 women who knew the oncogenic
nature of HPV, three had received HPV vaccination, but only
one knew the brand of the vaccine (Figure 2). 
As for the self-sampling perception survey, only 10 (18.2%) of
the participants provided their responses. Only 40% (n=4/10)
stated that they preferred self-sampling, and half of them
stated that self-sampling was easy to perform while the other
half found it difficult. The two participants who found self-
sampling easy provided self-collected vaginal samples
without expressing any concern. One of the other two
Table I: Demographic information on the consenting women according to age cohorts, Ethnicity, Employment and education status
Age Negative Positive Total
20-29 13 0 13
30-39 13 1(1.85%) 14
40-49 19 0 19
50-59 5 0 5
60-69 2 0 2
70+ 2 0 2









Education Primary Secondary Tertiary
30(54.5%) 22(40.0%) 3(5.5%)
Employment Unemployed Self-employed Employed
42(76.4%) 9(16.4%) 4(7.3%)
a classified under ethnic Orang Ulu (people of the interior)
b classified under ethnic Dayak
Fig. 1: The sampling journey in Long Banga, Small District of Bario, Sarawak. [The duration is approximate in hour(h)].
Fig. 2: HPV literacy survey completed by 55 (100%) of the respondents.
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participants who found self-sampling to be difficult and was
concerned if she had done it right, but the other did not
express any concern. Majority of the participants (60%; n=6)
who have responded mentioned that they preferred clinician-
collection over self-sampling, and all of them found self-
sampling to be difficult and expressed concern whether they
have done the procedure correctly (Figure 3).
DISCUSSION
This is an active population-based HRHPV prevalence study
where sampling was carried out at the remote villages in
Long Banga rather than hospital-based as done by other
researchers. The prevalence of HRHPV in Long Banga was
determined to be 1.85% (n=1/55), which is much lower than
the prevalence of 8% (n=6/75) in Bario town, using the same
assay in 2019.21 Considering both studies, the updated
prevalence of HRHPV in the small district of Bario would be
5.38% (n=7/130), similar to the population-based HRHPV
prevalence in other states in Malaysia such as Sabah (4.6%)22
and Selangor (6.5%).23 However, other researchers have
reported a much higher prevalence in Peninsular Malaysia,
ranging between 25.6-46.7%.24-26
The sole HRHPV positive woman was a Penan in the age-
cohort 30-39, which is consistent with the national cervical
cancer incidence trend, which increases at age >35 years and
peaks between 50-74 years old.11 However, we are not able to
determine if the positivity correlates with cervical
intraepithelial neoplasia as we did not follow-up with
cytological test in this study. 
All participants had attended some level of formal education.
More than half of the women had reported attending at least
primary education, which was not surprising as primary
education is mandatory in Malaysia. Public-funded schools
are being offered to citizens for free, even in the deep interior
of Sarawak.27 Furthermore, the retention of females in school
is relatively high, at least true for primary education,28 and
we see that only 40% of the women have attended secondary
education. The three participants who had attended tertiary
education were government officials serving in the area, and
their higher level of awareness about HPV may have distorted
the actual HPV and cervical cancer awareness in the study
population.
The awareness of HPV was found to be inferior among the
women in Long Banga, which may be attributed to the lower
education level of the participants. Most other HPV
awareness studies had been carried out among the university
students and consistently found that higher education level
correlates with higher awareness on HPV and cervical
cancer,29-30 but even so, gaps exist such as the methods for
prevention, symptoms, and consequences of HPV infection.
Thus, intentional and targeted campaigns are required to
bring HPV and cervical cancer education to the hard-to-reach
populations to improve their awareness level.
The majority of the participants who have responded to the
questionnaire prefer clinician-collection over self-sampling.
This is an expected response from rural women who have
never been offered such a new method before. Their possible
unfamiliarity with their reproductive anatomy may increase
their fear of inflicting self-injury due to performing the
sampling technique incorrectly. However, they were still
willing to undergo self-sampling, indicating that self-
sampling can be an acceptable new norm and outweigh the
women's potential shyness to be inspected by medical
personnel. This is not surprising as a longitudinal study
conducted by Hood et al., have revealed that 47% of women
have initially indicated their unwillingness to perform self-
sampling. However, when given an opportunity, they would
seize the opportunity, meaning that offering an opportunity
is more important than the acceptability of self-sampling
method.31 Furthermore, population-based randomised trials
have also shown that self-sampling has resulted in a four-fold
increase in cervical cancer screening uptake,32,33 and HPV
education on the safety of self-collection can improve the
acceptance rate of the self-collection method.34
Self-sampling has provided the women in Long Banga with
accessibility to cervical cancer screening. It allows them to
have their cervicovaginal samples collected in their privacy
and at the time of COVID-19 pandemic without
compromising the strict standard operating procedures
imposed by the government. This study may not have
accomplished the screen and treat strategy recommended by
WHO, but the 55 women were successfully screened using a
more sensitive method than the traditional cytology offered
under the National Cervical Cancer Screening Programme.
At the time of writing, the small district of Bario and the rest
of the villages remained free from SARS-CoV-2 infection.
Fig. 3: Self-sampling perception survey completed by 10 (18.1%) of 55 women.
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This study has several limitations.1 The sample size represents
approximately 8.73% (n=55/630) of the female population in
Long Banga,35 and larger sample size is desired to improve
the significance of the data. We must highlight that postal
service is not available to the villagers and postal delivery of
self-sampling kit to individual addresses as described by
Kobetz et al., is impossible.36 We cannot discount the
possibility of improper sampling technique as it was carried
out in privacy of participants but other studies have shown
high-concordance between clinician-collection and self-
sampling;37-39 The careHPVTM Test lacks a housekeeping gene
such as beta-globin for internal control and, therefore not
possible to validate the adequacy of the starting material.
However, we must bear in mind that vaginal swab differs
from cervical swab as it targets free virions secreted into the
cervicovaginal fluid rather than cell-bound or genome-
integrated HPV DNA. Lastly, self-administered questionnaire
is open to self-report bias which could have been minimised
by having a full-time interviewer.
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